CDPHP Health Plans Continue to Rate Among the Highest for Quality in NY, Nation
/
Date20 Sep 2016
ALBANY, N.Y., Sept. 20, 2016 (GLOBE NEWSWIRE) — For more than 30 years, CDPHP has taken great pride in its commitment to quality, and that... Read More →
Masimo (MASI) Hits 52-Week High on Solid Growth Prospects
/
Date20 Sep 2016
Shares of Masimo Corp. MASI scaled a new 52-week high of $60.05 on Sep 19. This translates into an impressive year-to-date return of roughly 44.2%,... Read More →
Jacksonville Bancorp, Inc. (JXSB) Declares Dividend
/
Date20 Sep 2016
JACKSONVILLE, Ill., Sept. 20, 2016 (GLOBE NEWSWIRE) — Andrew F. Applebee, Chairman of Jacksonville Bancorp, Inc. (NASDAQ:JXSB), (the “Bancorp”) today announced that the Bancorp has... Read More →
Cesca Therapeutics Reports Fourth Quarter and Fiscal 2016 Year End Results
/
Date20 Sep 2016
RANCHO CORDOVA, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today reported fourth quarter and full... Read More →
Sharecare to Host Twitter Chat on Fitness and Physical Activity
/
Date20 Sep 2016
ATLANTA, Sept. 20, 2016 (GLOBE NEWSWIRE) — Sharecare, the digital health company helping people manage all their health in one place, will host a Twitter... Read More →
Nokia and T-Mobile showcase the real potential of 5G through network testing and applications
/
Date20 Sep 2016
Companies conclude preliminary 5G testing, using T-Mobile’s 28GHz spectrum and Nokia’s commercial 5G-ready AirScale radio platform Nokia and T-Mobile also collaborate on 5G demonstrations, highlighting... Read More →
KCAP Financial, Inc. Announces Quarterly Distribution
/
Date20 Sep 2016
NEW YORK, Sept. 20, 2016 (GLOBE NEWSWIRE) — The Board of Directors of KCAP Financial, Inc. (Nasdaq:KCAP) approved a cash distribution for the third quarter... Read More →
21st Century Oncology Holdings Inc. Reports First and Second Quarter 2016 Financial Results
/
Date20 Sep 2016
FORT MYERS, Fla., Sept. 20, 2016 (GLOBE NEWSWIRE) — 21st Century Oncology Holdings, Inc. (“21C” or the “Company”), the leading global provider of integrated cancer... Read More →
Adamas Announces Results of EASE LID 3, a Pivotal Trial of ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID) in Parkinson’s Disease Patients at the 4th World Parkinson Congress
/
Date20 Sep 2016
EMERYVILLE, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced the results of the EASE LID 3 study, the second Phase 3... Read More →
American Airlines to Donate $1M to Answer ALS Foundation
/
Date20 Sep 2016
FORT WORTH, Texas, Sept. 20, 2016 (GLOBE NEWSWIRE) — American Airlines this year will begin a multi-year financial commitment of $1 million to the Answer... Read More →